Barry co-founded Biolog and currently serves as President and Chairman of the Board of Directors. He has led the R&D efforts at Biolog since its inception, resulting in numerous issued or allowed U.S. and international patents. Prior to Biolog, he was a senior scientist and group leader at Genentech, Inc., working on production of recombinant proteins in microorganisms. Barry earned an S.B. in Biology and an S.M. from the Massachusetts Institute of Technology, a Ph.D. in Bioengineering from the University of Michigan, and was a Senior Postdoctoral Fellow in Biochemistry with Bruce N. Ames, Ph.D., at the University of California, Berkeley.

Edwin Fineman, Vice President of Finance, has more than 23 years experience in a wide range of finance, accounting and administrative roles in the medical diagnostic, business services, industrial products and computer industries. Ed has held positions of responsibility in companies ranging from start-up enterprises to large, publicly-traded multi-national corporations. Prior to joining Biolog, Ed was V.P. Finance and Corporate Controller for WageWorks, Inc; Director of Finance for Acuson Corporation and Divisional Controller for Raychem Corporation. Ed has a B.S. degree from the University of California, Berkeley and a M.B.A. degree from the University of Texas, Austin.

Doug has over 30 years of management experience in operations for diagnostic companies in the medical, agricultural, and microbiological fields. His previous experience includes direct management of manufacturing and materials functions for departments ranging from startup to 60 employees. Prior to joining Biolog, he was Vice President of Operations for ChemTrak, Inc. Doug's early career was in chemical processing, production, and inventory management with diagnostic subsidiaries of Smith Kline & French, and G. D. Searle. He was certified at the fellow level in MRP by the American Production and Inventory Control Society. He served as a noncommissioned officer with the U.S. Army Signal Corps, and has a B.A. in Chemistry with Honors from the University of California, Santa Cruz.

Mr. Pietrzyk brings 25 years of progressive senior-level business development experience in the life sciences. Prior to joining Biolog he was founder and president of Biomimetic Connection, a company active in university IP transfer, where he established multi-year service agreements with fourteen biomedical corporations.
Previously he was VPBD of Silicon Genetics, developing genomics software-hardware platform co-marketing agreements, and positioning the company for its aquisition by Agilent Technologies.
His research periods include 5 years as a senior research associate at AGRI, Inc. developing viral vaccines, 2 years as a medical researcher at Stanford University conducting mitochondrial research, and 2 years at the University of California, S.F. working on human growth hormones. He has a B.A. in physics from U.C. Berkeley, an M.A. in Cellular and Molecular Biology from California State University, S.F., and an M.B.A. from Dominican University.

Barry co-founded Biolog and currently serves as President and Chairman of the Board of Directors. He has led the R&D efforts at Biolog since its inception, resulting in numerous issued or allowed U.S. and international patents. Prior to Biolog, he was a senior scientist and group leader at Genentech, Inc., working on production of recombinant proteins in microorganisms. Barry earned an S.B. in Biology and an S.M. from the Massachusetts Institute of Technology, a Ph.D. in Bioengineering from the University of Michigan, and was a Senior Postdoctoral Fellow in Biochemistry with Bruce N. Ames, Ph.D., at the University of California, Berkeley.

Don co-founded Biolog and served as the Company's President and CEO, CFO and Corporate Secretary through 1999. Don began his career with Owens-Illinois, Inc. as an Industrial Engineer, and left to join Sinclair Koppers Company where he was promoted to Plant Manager. In 1971 and 1972, Don served as Deputy Chief of the Control Division, Pay Board, in the Executive Office of the President of the United States. From 1977 to 1980, he was a consultant to new venture start-ups and served as President of Innovative Design Company. He also served as an officer in the U.S. Army Signal Corps. Don received an S.B. in Chemical Engineering and an S.M. in Chemical Engineering Practice from the Massachusetts Institute of Technology, and an M.B.A. in Finance and Marketing from the Stanford University Graduate School of Business.

Dennis has held high positions in science and management in some of the most innovative and successful biotech companies. He obtained his Ph.D. in Biochemistry from the University of Sussex. In a 19 year career at Amersham he rose to the position of Vice President, R&D, North America. He has since held positions as Senior V. P., R&D and Business Development at Aclara Biosciences, Exec. V. P. R&D at Vitra Bioscience, CSO and V. P., Global R&D and Business Development at Serologicals Corporation and Corporate V. P. and CSO at Millipore Corporation. Dennis is currently CSO at IntegenX Inc., a Company he co- founded in 2003.

Phenotype MicroArray Board

Bruce N. Ames, Ph.D.
Kenn Rudd, Ph.D.
John M. Sedivy, Ph.D.

Microbiology Board

John L. Ingraham, Ph.D.
Elliot Juni, Ph.D.
Ralph S. Wolfe, Ph.D.